Association between body composition and recurrence in stage II-III colon cancer: a retrospective cohort study
Colorectal Cancer (CRC) is a common cause of cancer death and prognostic factors are used to determine management. Patients with advanced disease often become cachectic, losing skeletal muscle mass and density, as well as subcutaneous fat. CT can be used to assess body composition by measuring skeletal muscle area, density and subcutaneous and visceral fat. We hypothesise that evidence of sarcopenia or myosteatosis at diagnosis is associated with an increased risk of cancer recurrence. Patients discussed at the…
Using a machine learning model to measure CT body composition at L3 identified myosteatosis as an independent predictor of recurrence in stage II-III colon cancer.
Patients with stage II-III colon cancer whose CT body composition showed myosteatosis via machine learning analysis had significantly lower 5-year recurrence-free survival.
Evidence
- Peer-reviewedClinical Nutrition ESPEN2026-08-26
How should this claim be treated?
Truvace Impact Record TRV-2026-0920, v1: “Association between body composition and recurrence in stage II-III colon cancer: a retrospective cohort study.” Truvace, 2026-08-28. /record/TRV-2026-0920 (accessed at citation time). sha256 262955a4cbb875fb…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0920 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace